Background: In Brazil, there are few studies of the metabolic syndrome in the general population, and even fewer studies that establish a correlation between metabolic syndrome and climacteric.
Introduction
The epidemiology, case history and prognosis of cardiovascular diseases are different in men and women. Typically, women develop this type of disease ten years after men 1 . Among women aged 50 to 64, there is a considerable increase in cardiovascular risk 2 . This change in the cardiovascular risk profile coincides with the climacteric and it is characterized by the emergence or worsening of some risk factors: central obesity, systemic hypertension (SH) and dyslipidaemia. This set of factors, along with hyperglycemia or insulin resistance, comprises the concept of the metabolic syndrome (MS) 3, 4 .
The question about the role of menopause as a risk factor for MS was raised before the establishment of the syndrome concept as it is known today. Since the 70s, studies have shown
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Methods
Study design
Analytical and cross-sectional study conducted from February to September 2008 in the gynecology clinic of a tertiary public hospital, with the recruitment of 355 patients, 32 of whom refused to participate in the research.
Population
Climacteric women (aged 40 to 65) with symptoms, with an intact uterus and no hormonal therapy. They were divided into two groups: postmenopausal women and premenopausal women.
The sample size calculation, considering the MS prevalence of 30%, confidence interval of 5%, absolute accuracy of 3%, was of 323 patients.
Definitions
Climacteric -Period of the woman's life between the end of the reproductive phase and the onset of senescence (40-65 years) 12 .
Symptomatic climacteric -It is characterized by: vasomotor instability, irregular menstrual bleeding, psychological symptoms and genitourinary atrophy 13 .
Menopause -Last spontaneous menstruation
.
Premenopause -Period during which climacteric women still have menstrual cycles, whether such cycles are regular or not 13 .
Perimenopause or menopausal transition -Period that extends from two years before the last menstruation and until one year later. Women have irregular menstrual cycles and endocrine changes 13 .
Postmenopause -Period that starts one year after the last menstruation. It is subdivided into early (up to five years after the last menstruation) or late (more than five years after the last menstruation) 13 . . According to the IDF, the diagnosis is made by the presence of abdominal obesity (AC≥80 cm) plus two criteria among those presented in Table 1 4 .
Metabolic syndrome -
Data collection
A registration form was filled out. This form contained: age, group (pre or postmenopausal), race, occupation, personal and family history, smoking, alcoholism, medicines, blood pressure, abdominal circumference (AC), hip circumference (HC), BMI, triglycerides, HDL-C, fasting blood glucose.
For "age", four categories were adopted: ages 40 to 45; 46 to 50; 51 to 55 and 56 to 65. For "occupation," three categories were adopted: non-manual; manual and out of the economically active population (EAP). The data were entered into MS-Excel™ (Microsoft, Charlotte, NC, USA) and then exported to Stata™ 10.0 (StataCorp, College Station, TX, USA) for statistical analysis.
Statistical analysis
The data were presented as mean, standard deviation, percentages, odds ratios and confidence intervals.
The relationship between the menopausal status and MS was observed in a simple logistic regression model, with the odds ratio and its confidence interval being estimated at 95%. We also conducted a bivariate analysis of age group, race and occupation in relation to MS. In a multiple logistic regression model, we calculated the odds ratio of the menopausal status in relation to MS, adjusted for age group, race and occupation. The analyses were carried out separately for NCEP and IDF criteria. A p value higher than 0.05 was considered statistically significant.
Ethical aspects
The data were collected after the institution's Research Ethics Committee gave its approval, and the patients signed an Informed Consent Form.
Results
The average age of the population studied was 49.7 years. The prevalence of MS by NCEP criteria was 34.7% (112 cases), while by the IDF, it was 49.85% (161 cases).
O u t o f t h e 3 2 3 w o m e n , 1 5 4 ( 4 7 . 6 8 % ) w e r e premenopausal and 169 (52.32%) were postmenopausal. MS was more prevalent among postmenopausal women than among premenopausal women by both criteria. According to the NCEP criteria, 44.4% of postmenopausal women had MS, compared to 24% of premenopausal women -OR=2.52 (CI = 1.56 to 4.07), p<0.001. And by the IDF, MS was present in 61.5% of postmenopausal With respect to age, the older the patient was, the more frequent the MS became, with a statistically significant relationship between age and occurrence of MS by both criteria (p<0.001).
When the NCEP concept was used, there was no statistically significant relationship (p=0.228) between race and the occurrence of MS, despite its greater frequency among black people (42.9%), followed by white people (37.9 %) and mixed race people (31%). This relationship was not observed when the IDF concept was used (p=0.323), although the MS was more prevalent among black women (59.2%), followed by mixed race (49.2%) and white (46%).
With respect to occupations, it was observed that the MS was prevalent among women outside the economically active population (EAP) in both diagnosis protocols. By the NCEP criteria, MS was present in 42.2% of women outside the EAP, in 29.8% of those with non-manual occupations and in 29.7% of women with manual occupations (p=0.071). There was also no statistical relationship between the occupation categories and the prevalence of MS by the IDF criteria (p=0.110).
The prevalence of MS, distributed according to age, menopausal status, race and occupation, is shown in Table 2 (NCEP) and Table 3 
(IDF).
When the components of MS were examined separately, low HDL-C was prevalent among 79.6% of the patients (n=257), followed by systemic hypertension in 65% of patients (n=210), hypertriglyceridemia in 12.4% (n=40) and hyperglycemia in 11.8% (n = 38).
Abdominal obesity was prevalent among 40.9% (n=132) of the individuals, by the NCEP criteria (AC≥88 cm), and among 81.1% (n = 262), according to the IDF concept (AC≥80 cm).
The prevalence of all components studied was higher among postmenopausal women than among premenopausal women, where only abdominal obesity and systemic hypertension were statistically significant (AC-IDF p=0.049) (AC-NCEP p <0.001) (systemic hypertension, p=0.001) ( Table 4 ).
The number of components among patients with MS was also analyzed. According to the NCEP concept, 73.2% of women with MS had three, 19.6% had four, and 7.1% had all five MS components. When the IDF criterion was used, 77.6%, 15.5% and 6.8% of the women with MS had, respectively, three, four and five components.
With respect to the menopausal status, the number of components among the patients with SM increased among postmenopausal women, by both diagnosis criteria.
There was a statistically significant relationship between the increase in age and the prevalence of MS, by the NCEP concept (p<0.001) and by the IDF concept (p=0.005). By the NCEP criteria, there was a 15-fold increase in the risk of MS among women aged 56 to 65 (OR=14.87; CI 4.24 to 52.13) compared to those between 40 and 45 years old. There was also a significant increase (7.5 times) in the risk of MS when the same age groups were compared according to the IDF concept. (OR=7.5 CI 2.18 to 26.07) 
-Abdominal circumference by the criterion of the International Diabetes Federation. 2 -Abdominal circumference by the criterion of the National Cholesterol Education Program -Adult Treatment Panel III. n -number of individuals. (*) Chi-square test.
With regard to menopausal status, race and occupation, the multivariate analysis revealed no statistically significant relationship between these variables and the occurrence of MS (Table 5 -NCEP) (Table 6 -IDF). 
-MS NCEP -Metabolic syndrome according to the definition of the National Cholesterol Education Program -Adult Treatment Panel III. 2 -Economically
Active Population.
Discussion
The MS concept has been around for several decades, but it was only after the standardization of diagnostic criteria that it was possible to compare prevalence between populations. Differences in genetic profile, eating habits, level of physical The prevalence of MS in women varies a lot. According to the characteristics of the population studied and the diagnostic criteria adopted, the prevalence ranges from 10.7% among Korean women above 30 years-old by the NCEP criteria 14, 15 , to 74% in post-menopausal women with coronary artery disease in Birmingham (USA) by the IDF 16 .
The overall prevalence of MS by NCEP, in this study, was 34 By the IDF criteria, there was higher prevalence of MS among postmenopausal women (61.5%) compared to premenopausal women (37%). Among menopausal Chinese women, Ding et al 21 found 37.3% of MS (IDF). Socio-cultural influences, eating habits, sedentary lifestyle and different levels of urbanization among the populations also change the prevalence of MS, which may explain this difference.
As to the age group, this study found an increasing prevalence of MS. According to NCEP criteria, 14.1% of the 40 to 45 age group and 66.7% of the 56 to 64 age group. By the IDF concept, 33.3% and 82.4% of the same age groups. This finding was statistically significant in both the univariate analysis and multivariate analysis. In Brazil, epidemiological data referring to MS in the general population are scarce and rarer still with regard MS among climacteric women. A study conducted in the semiarid region of Bahia State with 138 women found 18.2% of MS (NCEP-2001) among women under the age of 45 and 56.9% among those that were 45 years or older 22 . A study conducted in the city of Vitória, State of Espírito Santo, which evaluated 887 women, found prevalence of MS (NCEP-2001) of 33.6% in women aged 45 to 54 and 53.4% among those aged 55 to 64 23 . A study conducted in Seychelles found prevalence of 46% and 68% among women in the 45 to 54 and 55 to 64 age groups 24 .
The genetic aspect may contribute to the high prevalence found in this study, because the Negroid features are widely distributed in the population studied (73.1% black women/ mixed-race women). The same occurs in the populations studied in Bahia 22 (84.3%) and Espírito Santo 23 (66.8%). It is important to highlight the high frequency of metabolicsyndrome components among African descendants, such as systemic hypertension at an earlier stage and more prevalent, obesity and type 2 DM, particularly in black women 22 .
When the components of MS are examined separately, the change most frequently found was abdominal obesity by the IDF criteria (AC ≥ 80 cm), with frequency of 81.1%. As the IDF criterion for abdominal obesity is more stringent than the NCEP criterion (AC ≥ 88 cm), and as climacteric women showed a statistically significant increase in AC, this component became the most frequent one, followed by low HDL-c (79.6%), systemic hypertension (65%), abdominal obesity (NCEP) (40.9%), hypertriglyceridemia (12.4%) and fasting hyperglycemia (11.8%). When all the components of MS were analyzed in relation to menopausal status, the same order of frequency was maintained, and all changes were more common in the postmenopausal group. Oliveira et al 22 found the same frequency order, in the following percentages: 84.1%, 53.6%, 47.1%, 18.1% and 16.7%. In the city of Vitoria, State of Espírito Santo, there was an inversion only in the first two components. The other ones followed the same order 23 .
In a study conducted in the city of Porto Alegre, 5.1% of women had an aggregate of four to five risk factors for cardiovascular disease, and 4.5% had a combination of high blood pressure and diabetes, which are two of the MS components 25 .
Oh et al 15 studied 449 South Korean women and the most frequent components were: Low HDL-c, systemic hypertension, hypertriglyceridemia, hyperglycemia and abdominal obesity. According to the authors, the genetic characteristics of the Korean population are responsible for this lower prevalence of abdominal obesity.
The studies that are aimed at demonstrating the correlation between menopause and cardiovascular risk factors, including MS, are contradictory. A higher prevalence of each factor and the MS among menopausal women than among women of childbearing age is the most common result. In the 1980s and 1990s, Staessen et al. demonstrated that menopausal women and older women had higher BP than premenopausal and younger women 26, 27 . In 1987, Villecco et al 28 found a "temporary increase in BP, related to ovarian failure." Hjortland et al 29 monitored 1,686 climacteric women and found no significant difference in weight, BP and blood glucose in postmenopausal women.
A recent review in California that linked surgical menopause with cardiovascular risk failed to allow the desired meta-analysis due to the heterogeneity of the results found, also due to methodological errors of the studies 30 .
These conflicting results may be attributed to several factors: different study designs, population studied, age, time since menopause, spontaneous or surgical menopause, diagnostic criteria of MS and even serious methodological errors. In a study conducted at the University of Bristol, for example, the "menopausal" status was assigned to every woman over 50, arguing that "this is the average age of menopause for British women 31 ."
Before so many confounding factors, it becomes difficult to draw any definitive conclusion from these studies. There is widespread belief that women lose the "cardiovascular advantage" after menopause, and this increases cardiovascular morbidity and mortality 32 . The decline in ovarian function is considered the cause of this phenomenon 9, 33, 34 .
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Statistics available do not provide support for a definitive conclusion about the role of menopause as an independent risk factor for the increase in the prevalence of MS. In this study, there was a higher prevalence of MS among menopausal women when both diagnostic criteria were considered, but this difference was not statistically significant after the adjustment for age, which differs from most studies. The agegroup stratification was statistically significant in the univariate analysis and multivariate analysis. Therefore, our results allow us to conclude that, in the study population, the increase in the prevalence of metabolic syndrome among postmenopausal women was caused mainly by the age increase.
Casiglia et al 35 , in a study with 9,364 Italian men and women found results that were similar to the ones of this study: higher prevalence of MS components among postmenopausal women, but this difference disappeared after adjustment for age. In the study conclusion, the authors mentioned that "the cardiovascular effects usually attributed to menopause seem to be merely a consequence of the older age of menopausal women 35 ."
The issue involving the role of menopause as a risk factor for the onset of MS and its effects remains controversial. A limitation of this study was the small population studied, although the results are consistent with many other studies 8, 9, 19, 22, 23 . Due to the ethnic and cultural heterogeneity of the population of this region, other studies are needed to confirm the results found and, then, take actions to prevent MS in climacteric women.
Conclusion
MS was more prevalent among postmenopausal women than among premenopausal women by both criteria. Menopause is not an independent risk factor for metabolic syndrome. Age is the main independent risk factor for the occurrence of MS.
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